Magnetic resonance imaging in the evaluation of iron overload: A comparison of MRI, echocardiography and serum ferritin level in patients with β-thalassemia major

Clinical Imaging

Volumn 36, Issue 5, 2012, Pages 483-488

  Shamsian, Bibi Shahin ^a   Abdar Esfahani, Shadi ^a   Milani, Hani ^a   Akhlaghpoor, Shahram ^b   Mojtahedzadeh, Saeid ^a   Karimi, Abdollah ^a   Shamshiri, Ahmad Reza ^a   Alavi, Samin ^a   Safari, Alieh ^a   Rezaei, Nima ^c,d   Arzanian, Mohammad Taghi ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

thalassemia major; Heart; Iron overload; Liver; Magnetic resonance imaging

Indexed keywords

CONVENTIONAL TECHNIQUES; HEPATIC TISSUE; IRON CONCENTRATIONS;

BODY FLUIDS; ECHOCARDIOGRAPHY; HISTOLOGY; IRON; LIVER; MAGNETIC RESONANCE IMAGING; TISSUE;

HEART;

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HEART HEMOSIDEROSIS; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IRON CHELATION; IRON OVERLOAD; IRON STORAGE; LIVER BIOPSY; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BIOPSY; CHELATION THERAPY; CHI-SQUARE DISTRIBUTION; CHILD; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITINS; HEPATITIS C; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84865367769     PISSN: 08997071     EISSN: 18734499     Source Type: Journal    
DOI: 10.1016/j.clinimag.2011.11.029     Document Type: Article

References (27)

1. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson 2008, 10:12.
2. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001, 22(23):2171-2179.
3. Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005, 75(3):241-247.
4. Daar S, Pathare AV, Jain R, Zadjali SA, Pennell DJ T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman. Haematologica 2009, 94(1):140-141.
5. Modell B, Khan M, Darlison M Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000, 355(9220):2051-2052.
6. Pennell DJ T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 2005, 1054:373-378.
7. Wacker P, Halperin DS, Balmer-Ruedin D, Oberhansli I, Wyss M Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993, 103(4):1276-1278.
8. Henry WL, Nienhuis AW, Wiener M, Miller DR, Canale VC, Piomelli S Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med 1978, 64(4):547-555.
9. Buja LM, Roberts WC Iron in the heart. Etiology and clinical significance. Am J Med 1971, 51(2):209-221.
10. Barry M, Sherlock S Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971, 1(7690):100-103.
11. Crosby WH Editorial: Serum ferritin fails to indicate hemochromatosis - nothing gold can stay. N Engl J Med 1976, 294(6):333-334.
12. Brittenham GM, Badman DG Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003, 101(1):15-19.
13. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E Thalassemia. Hematology Am Soc Hematol Educ Program 2004, 14-34.
14. Shabanian R, Heidari-Bateni G, Kocharian A, Mashayekhi M, Hosseinzadeh S, Kiani A, et al. Augmentation of left atrial contractile function: a herald of iron overload in patients with beta thalassemia major. Pediatr Cardiol;31(5):680-8.
15. Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009, 113(20):4853-4855.
16. Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, et al. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006, 28(5):311-315.
17. Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100(1):17-21.
18. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003, 101(11):4632-4639.
19. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004, 103(5):1934-1936.
20. Chan YL, Li CK, Lam CW, Yu SC, Chik KW, To KF, et al. Liver iron estimation in beta-thalassaemia: comparison of MRI biochemical assay and histological grading. Clin Radiol 2001, 56(11):911-916.
21. Bonetti MG, Castriota-Scanderbeg A, Criconia GM, Mazza P, Sacco M, Amurri B, et al. Hepatic iron overload in thalassemic patients: proposal and validation of an MRI method of assessment. Pediatr Radiol 1996, 26(9):650-656.
22. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005, 106(4):1460-1465.
23. Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983, 36(5):539-545.
24. Olivieri NF, Brittenham GM Iron-chelating therapy and the treatment of thalassemia. Blood 1997, 89(3):739-761.
25. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004, 126(5):736-742.
26. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet 1989, 2(8653):27-30.
27. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007, 29(4):233-238.